There is an A33-dependent mechanism for the incorporation of B5-GFP into vaccinia virus extracellular enveloped virions

Virology

Volumn 402, Issue 1, 2010, Pages 83-93

  Chan, Winnie M ^a   Ward, Brian M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

A33R; B5R; B5R GFP; Extracellular enveloped virus; Glycoprotein incorporation; Intracellular enveloped virus; Orthopoxvirus; Poxvirus; Protein interaction; Vaccinia

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; PROTEIN B5R; UNCLASSIFIED DRUG; VIRUS PROTEIN; A33R PROTEIN, VACCINIA VIRUS; B5 PROTEIN, VACCINIA VIRUS; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MATRIX PROTEIN; MEMBRANE PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; BINDING ASSAY; CELL LINE; CONTROLLED STUDY; HELA CELL; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINIA VIRUS; VIRION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS RECOMBINANT; CHEMISTRY; GENE DELETION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; VIRUS ASSEMBLY;

ORTHOPOXVIRUS; POXVIRIDAE; VACCINIA VIRUS;

GENE DELETION; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; RECOMBINANT FUSION PROTEINS; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS; VIRION; VIRUS ASSEMBLY;

EID: 77952568117     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.03.017     Document Type: Article

References (42)

1. Appleyard G., Hapel A.J., Boulter E.A. An antigenic difference between intracellular and extracellular rabbitpox virus. J. Gen. Virol. 1971, 13:9-17.
2. Blasco R., Moss B. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000- Dalton outer envelope protein. J. Virol. 1991, 65(11):5910-5920.
3. Blasco R., Moss B. Role of cell-associated enveloped vaccinia virus in cell-to-cell spread. J. Virol. 1992, 66(7):4170-4179.
4. Blasco R., Sisler J.R., Moss B. Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene. J. Virol. 1993, 67(6):3319-3325.
5. Chen Y., Honeychurch K.M., Yang G., Byrd C.M., Harver C., Hruby D.E., Jordan R. Vaccinia virus p37 interacts with host proteins associated with LE-derived transport vesicle biogenesis. Virol. J. 2009, 6:44.
6. Duncan S.A., Smith G.L. Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. J. Virol. 1992, 66:1610-1621.
7. Earl P.L., Moss B. Generation of Recombinant Vaccinia Viruses. Current Protocols in Molecular Biology 1991, vol. 2:16.17.1-16.17.16. Greene Publishing Associates & Wiley Interscience, New York. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, K. Struhl (Eds.).
8. Earley A.K., Chan W.M., Ward B.M. The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions. J. Virol. 2008, 82(5):2161-2169.
9. Engelstad M., Howard S.T., Smith G.L. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 1992, 188:801-810.
10. Geada M.M., Galindo I., Lorenzo M.M., Perdiguero B., Blasco R. Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein. J. Gen. Virol. 2001, 82(Pt 11):2747-2760.
11. Hiller G., Weber K. Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment. J. Virol. 1985, 55(3):651-659.
12. Hirt P., Hiller G., Wittek R. Localization and fine structure of a vaccinia virus gene encoding an envelope antigen. J. Virol. 1986, 58:757-764.
13. Hollinshead M., Rodger G., Van Eijl H., Law M., Hollinshead R., Vaux D.J., Smith G.L. Vaccinia virus utilizes microtubules for movement to the cell surface. J. Cell Biol. 2001, 154(2):389-402.
14. Hooper J.W., Custer D.M., Schmaljohn C.S., Schmaljohn A.L. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge. Virology 2000, 266(2):329-339.
15. Isaacs S.N., Wolffe E.J., Payne L.G., Moss B. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. J. Virol. 1992, 66(12):7217-7224.
16. Law M., Carter G.C., Roberts K.L., Hollinshead M., Smith G.L. Ligand-induced and nonfusogenic dissolution of a viral membrane. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(15):5989-5994.
17. Lorenzo M.D., Herrera E., Blasco R., Isaacs S.N. Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail. Virology 1998, 252(2):450-457.
18. Mathew E., Sanderson C.M., Hollinshead M., Smith G.L. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation. J. Virol. 1998, 72:2429-2438.
19. Moss B. Poxviridae: the Viruses and Their Replication. Fields Virology 2001, vol. 2:2849-2883. Lippincott-Raven Publishers, Philadelphia, 2 vols. Fourth ed. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
20. Moss B. Poxvirus entry and membrane fusion. Virology 2006, 344(1):48-54.
21. Payne L.G. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J. Gen. Virol. 1980, 50(1):89-100.
22. Perdiguero B., Blasco R. Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins. J. Virol. 2006, 80(17):8763-8777.
23. Reeves P.M., Bommarius B., Lebeis S., McNulty S., Christensen J., Swimm A., Chahroudi A., Chavan R., Feinberg M.B., Veach D., Bornmann W., Sherman M., Kalman D. Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. Nat. Med. 2005, 11(7):731-739.
24. Rietdorf J., Ploubidou A., Reckmann I., Holmstrom A., Frischknecht F., Zettl M., Zimmermann T., Way M. Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus. Nat. Cell Biol. 2001, 3(11):992-1000.
25. Roberts K.L., Breiman A., Carter G.C., Ewles H.A., Hollinshead M., Law M., Smith G.L. Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane. J. Gen. Virol. 2009, 90(Pt 7):1582-1591.
26. Robinson M.S. Adaptable adaptors for coated vesicles. Trends Cell Biol. 2004, 14(4):167-174.
27. Roper R.L., Payne L.G., Moss B. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J. Virol. 1996, 70(6):3753-3762.
28. Roper R.L., Wolffe E.J., Weisberg A., Moss B. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J. Virol. 1998, 72(5):4192-4204.
29. Rottger S., Frischknecht F., Reckmann I., Smith G.L., Way M. Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J. Virol. 1999, 73(4):2863-2875.
30. Schmelz M., Sodeik B., Ericsson M., Wolffe E.J., Shida H., Hiller G., Griffiths G. Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J. Virol. 1994, 68(1):130-147.
31. Smith G.L., Vanderplasschen A., Law M. The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 2002, 83(Pt 12):2915-2931.
32. Su H.P., Singh K., Gittis A.G., Garboczi D.N. The structure of the poxvirus A33 protein reveals a dimer of unique C-type lectin-like domains. J. Virol. 2010, 84(5):2502-2510.
33. Tooze J., Hollinshead M., Reis B., Radsak K., Kern H. Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur. J. Cell Biol. 1993, 60(1):163-178.
34. van Eijl H., Hollinshead M., Smith G.L. The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology 2000, 271(1):26-36.
35. van Eijl H., Hollinshead M., Rodger G., Zhang W.H., Smith G.L. The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J. Gen. Virol. 2002, 83(Pt 1):195-207.
36. Ward B.M. Visualization and characterization of the intracellular movement of vaccinia virus intracellular mature virions. J. Virol. 2005, 79:4755-4763.
37. Ward B.M. Using fluorescent proteins to study poxvirus morphogenesis. Methods Mol. Biol. 2009, 515:1-11.
38. Ward B.M., Moss B. Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein. J. Virol. 2000, 74(8):3771-3780.
39. Ward B.M., Moss B. Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails. J. Virol. 2001, 75(23):11651-11663.
40. Ward B.M., Moss B. Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera. J. Virol. 2001, 75(10):4802-4813.
41. Ward B.M., Weisberg A.S., Moss B. Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins. J. Virol. 2003, 77(7):4113-4126.
42. Wolffe E.J., Weisberg A.S., Moss B. The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein. J. Virol. 2001, 75(1):303-310.